X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Manufacturing

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

Content Team by Content Team
27th August 2022
in Manufacturing, Press Statements
Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Greene Tweed, a leading global manufacturer of high-performance sealing solutions and engineered components, will be showcasing its products for the chemical processing, life sciences(pharmaceutical/analytical), and hydrogen/clean technologies markets at ACHEMA 2022, from August 22-26, 2022, at Messe Frankfurt GmbH in Frankfurt am Main, Germany, Hall 9.0, Booth B 37.

Greene Tweed’s global team will be available to discuss the vast portfolio of elastomer, thermoplastic, and thermoplastic composite materials/products, capable of operating in the most chemically aggressive media, such as ethylene oxide.  Several case studies will be available for detailed discussions focusing on challenging applications.  Areas of focus will include Greene Tweed’s WR®/AR® and Xycomp® composites which significantly reduce life cycle costs by greatly extending equipment mean-time between repair (MTBR), as well as increasing equipment efficiency.

Greene Tweed Highlights Materials for Chemical Processing, Life Sciences, and Hydrogen Power Markets at ACHEMA 2022

On display will be Greene Tweed’s portfolio of sealing solutions for pharmaceutical processing, including seals, gaskets, o-rings, and MSE® Metal Spring Energized seals that meet the industry’s stringent cleanliness, traceability, FDA, and regulatory compliance needs.  Interested visitors can discuss custom-engineered solutions made from chemical-resistant Chemraz® FFKM and Fusion™ FKM that meet or exceed quality requirements, including United States Pharmacopeia (USPVI), FDA, and ISO product standards. With low leachable profiles, these specialty compounds maintain their inert nature in highly demanding conditions.

Visitors to the booth can also see a wide range of solutions ideal for hydrogen valves, compressors, instrumentation, electrolysers, and fuel cells. Greene Tweed materials offer exceptional stability under hydrogen exposure and can withstand such challenges as hydrogen permeation, material outgassing, or degradation of mechanical properties at increased temperatures. The portfolio also includes materials to enhance fuel cell and electrolyser performance.

Previous Post

By 2030, Offshore Formulation Development To Be Worth $60bn

Next Post

Moderna Sues Pfizer, BioNTech For mRNA COVID-19 Vaccinations

Related Posts

FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Insights

Green Chemistry in Sustainable API Manufacturing

26th September 2025
active pharmaceutical ingredients supply chain
Drug Development

Future of Active Pharmaceutical Ingredients Supply

26th September 2025
pharmaceutical excipients for new therapies
Drug Development

Advances in Pharmaceutical Excipients for New Therapies

26th September 2025
Next Post
Moderna Announces the EC's Approval of Advance Purchase Agreement for Initial 80 Million Doses of mRNA Vaccine Against COVID-19

Moderna Sues Pfizer, BioNTech For mRNA COVID-19 Vaccinations

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In